Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025.

Rheumatology (Oxford, England)·2025

Same author

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025.

The British journal of dermatology·2025

Same author

Isolated neurosarcoidosis presenting as granulomatous hypophysitis complicated by arginine vasopressin deficiency.

Clinical and experimental rheumatology·2025

Same author

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024.

Rheumatology (Oxford, England)·2024

Same author

British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024.

The British journal of dermatology·2024

Same author

Rheumatology research in Arab countries.

Saudi medical journal·2024

Search research articles

Related Experiment Video

Updated: May 31, 2026

PET/CT With [68Ga]-NOTA-FAP-2286 for Imaging of Tendon Injuries in Rat Achilles Tendon Injury Models

PET/CT With [⁶⁸Ga]-NOTA-FAP-2286 for Imaging of Tendon Injuries in Rat Achilles Tendon Injury Models

Published on: June 6, 2025

PET/CT imaging in inflammatory myopathies.

Adil Al-Nahhas¹, Ali S M Jawad

¹Department of Nuclear Medicine, Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom. Adil.al-nahhas@imperial.nhs.uk

Annals of the New York Academy of Sciences

|July 2, 2011

Summary

Idiopathic inflammatory myopathies, or inflammatory muscle diseases, can be challenging to diagnose. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) shows promise for detecting these conditions and guiding treatment.

More Related Videos

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Related Experiment Videos

Last Updated: May 31, 2026

PET/CT With [68Ga]-NOTA-FAP-2286 for Imaging of Tendon Injuries in Rat Achilles Tendon Injury Models

PET/CT With [⁶⁸Ga]-NOTA-FAP-2286 for Imaging of Tendon Injuries in Rat Achilles Tendon Injury Models

Published on: June 6, 2025

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Area of Science:

Neurology
Radiology
Immunology

Background:

Idiopathic inflammatory myopathies cause muscle weakness and fatigue, often linked to cancer.
Diagnosis relies on clinical signs, elevated creatine kinase, and muscle biopsy.
Current imaging like MRI has limitations in sensitivity and scope.

Purpose of the Study:

To evaluate the utility of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in diagnosing inflammatory muscle diseases.
To explore FDG PET/CT's role in assessing disease extent and monitoring treatment response.
To highlight the potential of FDG PET/CT in identifying associated malignancies in paraneoplastic syndromes.

Main Methods:

Review of existing literature on FDG PET/CT in inflammatory muscle diseases.
Analysis of case studies demonstrating FDG PET/CT findings in idiopathic inflammatory myopathies.
Comparison of FDG PET/CT performance against conventional diagnostic methods like MRI.

Main Results:

FDG PET/CT can detect inflammatory myopathies and assess disease activity.
The technique shows potential for monitoring therapeutic responses in these conditions.
FDG PET/CT is valuable for screening malignancies in patients with paraneoplastic syndromes.

Conclusions:

FDG PET/CT offers a valuable metabolic imaging approach for inflammatory muscle diseases.
Further research is warranted to establish FDG PET/CT as a routine diagnostic and management tool.
This imaging modality may improve diagnostic accuracy and patient outcomes.